Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4012)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 27, 2023 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524 [PMID: 37206650 DOI: 10.4254/wjh.v15.i4.515] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i4/515.htm |
| Number | Citing Articles |
| 1 |
Wen Liu, Jun Deng, Xiao-Jun Tao, Ya Peng, Xiang-Ding Chen, Xiao-Chao Qu, Hong-Wen Deng, Li-Jun Tan. Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3. International Journal of Oncology 2024; 65(4) doi: 10.3892/ijo.2024.5680
|
| 2 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 3 |
Xi Mao, Xiaoya Zhu, Tong Pan, Zehui Liu, Pingping Shangguan, Yi Zhang, Yingle Liu, Xiwen Jiang, Qi Zhang. Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71495-z
|
| 4 |
Zhenyu Wen, Junxiao Wang, Bo Tu, Yane Liu, Yuqing Yang, Li Hou, Xiang Yang, Xiaoyan Liu, Hui Xie. Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial. Cancer Medicine 2023; 12(20): 20311 doi: 10.1002/cam4.6602
|
| 5 |
Orane Lorton, Pauline Coralie Guillemin, Andrea Peloso, Yacine M’Rad, Lindsey Alexandra Crowe, Thibaud Koessler, Pierre-Alexandre Poletti, Sana Boudabbous, Alexis Ricoeur, Rares Salomir. In Vivo Thermal Ablation of Deep Intrahepatic Targets Using a Super-Convergent MRgHIFU Applicator and a Pseudo-Tumor Model. Cancers 2023; 15(15): 3961 doi: 10.3390/cancers15153961
|
| 6 |
Tiffany Nakla, Jacqueline J. Chow, Kathleen Pham, Nadine Abi-Jaoudeh. Non-Thermal Liver Ablation: Existing and New Technology. Seminars in Interventional Radiology 2023; 40(06): 497 doi: 10.1055/s-0043-1777844
|
| 7 |
Ching-Lung Hsieh, Cheng-Ming Peng, Chun-Wen Chen, Chang-Hsien Liu, Chih-Tao Teng, Yi-Jui Liu. Benefits and drawbacks of radiofrequency ablation <i>via</i> percutaneous or minimally invasive surgery for treating hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2024; 16(11): 3400-3407 doi: 10.4240/wjgs.v16.i11.3400
|
| 8 |
Wen-jun Pei, Hao Zhou, Ying Zeng, Qi-lin Ji, Jing-jing Zhang, Xiu Wang. 3-Bromopyruvate modified with cholesterol enhances anti-hepatoma activity by inducing ferroptosis and apoptosis. Journal of Drug Delivery Science and Technology 2024; : 106426 doi: 10.1016/j.jddst.2024.106426
|